Page 20 - Read Online

Page 8 of 8 Fiordoliva et al. J Cancer Metastasis Treat 2019;5:59 I http://dx.doi.org/10.20517/2394-4722.2019.23

recurrent prostate cancer after androgen deprivation therapy. BJU Int 2001;88:982-3.
21. Lapuk AV, Wu C, Wyatt AW, McPherson A, McConeghy BJ, et al. From sequence to molecular pathology, and a mechanism
driving the neuroendocrine phenotype in prostate cancer. J Pathol 2012;227:286-97.
22. Péqueux C, Keegan BP, Hagelstein MT, Geenen V, Legros JJ, et al. Oxytocin- and vasopressin-induced growth of human small-
cell lung cancer is mediated by the mitogen-activated protein kinase pathway. Endocr Relat Cancer 2004;11:871-85.
23. North WG, Cole B, Akerman B, Pang RH. Growth Impairment of Small-Cell Cancer by Targeting Pro-Vasopressin with MAG-
1 Antibody. Front Oncol 2014;11:4-16.
24. Miretti VS, Ávila RA, Sierra JT, García JJ, Laborié MV. Prostate carcinoma and syndrome of inappropriate antidiuretic
hormone secretion. Medicina (B Aires) 2018;78:290-3. (in Spanish).
25. Kawai S, Hiroshima K, Tsukamoto Y, Tobe T, Suzuki H, et al. Small cell carcinoma of the prostate expressing prostate-specific
antigen and showing syndrome of inappropriate secretion of antidiuretic hormone: an autopsy case report. Pathol Int 2003
Dec;53:892-6.